FibroBiologics Secures $100 Million Capital Commitment from GE...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
HOUSTON, Nov. 17, 2021 /PRNewswire-AsiaNet/ -- -- The Company plans to go public via SPAC, reverse merger, or a direct listing FibroBiologics, a clinical stage company developing fibroblast-based therapeutic cures for chronic diseases, announced today that it has signed an agreement with G...
Authors: LATEST ASIANET NEWS RELEASES